Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberta Palla

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Human Mutation|October 23, 2009
ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpuraLuca A Lotta, Isabella Garagiola, Roberta Palla, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2025
The genetic spectrum of rare bleeding disordersSamin Mohsenian, Omid Seidizadeh, Andrea Cairo, et al.
Blood|August 4, 2017
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysisFrits R Rosendaal, Roberta Palla, Isabella Garagiola, et al.
Thrombosis Research|November 18, 2016
Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disordersRoberta Palla, Simona M Siboni, Marzia Menegatti, et al.
Thrombosis and Haemostasis|November 25, 2010
Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathiesRoberta Palla, Carla Valsecchi, Mariateresa Bajetta, et al.
Blood Transfusion = Trasfusione Del Sangue|July 8, 2017
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysisAndrea Messori, Flora Peyvandi, Sabrina Trippoli, et al.
Pediatric Blood & Cancer|October 12, 2013
Congenital thrombotic thrombocytopenic purpura with novel mutations in three unrelated Turkish childrenAyse Metin, Sule Unal, Fatma Gümrük, et al.
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"Andrea Messori, Flora Peyvandi, Sabrina Trippoli, et al.
Biophysical Journal|May 27, 2008
Mechanistic studies on ADAMTS13 catalysisEnrico Di Stasio, Stefano Lancellotti, Flora Peyvandi, et al.
Blood|December 31, 2016
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia AAntonino Cannavò, Carla Valsecchi, Isabella Garagiola, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Human Mutation|October 23, 2009
ADAMTS13 mutations and polymorphisms in congenital thrombotic thrombocytopenic purpuraLuca A Lotta, Isabella Garagiola, Roberta Palla, et al.
Journal of Thrombosis and Haemostasis : JTH|June 12, 2025
The genetic spectrum of rare bleeding disordersSamin Mohsenian, Omid Seidizadeh, Andrea Cairo, et al.
Blood|August 4, 2017
Genetic risk stratification to reduce inhibitor development in the early treatment of hemophilia A: a SIPPET analysisFrits R Rosendaal, Roberta Palla, Isabella Garagiola, et al.
Thrombosis Research|November 18, 2016
Establishment of a bleeding score as a diagnostic tool for patients with rare bleeding disordersRoberta Palla, Simona M Siboni, Marzia Menegatti, et al.
Thrombosis and Haemostasis|November 25, 2010
Evaluation of assay methods to measure plasma ADAMTS13 activity in thrombotic microangiopathiesRoberta Palla, Carla Valsecchi, Mariateresa Bajetta, et al.
Blood Transfusion = Trasfusione Del Sangue|July 8, 2017
High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysisAndrea Messori, Flora Peyvandi, Sabrina Trippoli, et al.
Pediatric Blood & Cancer|October 12, 2013
Congenital thrombotic thrombocytopenic purpura with novel mutations in three unrelated Turkish childrenAyse Metin, Sule Unal, Fatma Gümrük, et al.
Blood Transfusion = Trasfusione Del Sangue|January 13, 2018
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"Andrea Messori, Flora Peyvandi, Sabrina Trippoli, et al.
Biophysical Journal|May 27, 2008
Mechanistic studies on ADAMTS13 catalysisEnrico Di Stasio, Stefano Lancellotti, Flora Peyvandi, et al.
Blood|December 31, 2016
Nonneutralizing antibodies against factor VIII and risk of inhibitor development in severe hemophilia AAntonino Cannavò, Carla Valsecchi, Isabella Garagiola, et al.
Pageof 5